Hasbrouck Heights, New Jersey 07604


Purpose:

During IVF cycles an embryo is generally placed into the uterine cavity between 3 and 5 days after fertilization. For a successful pregnancy to take place, that embryo must then implant in the properly primed and staged endometrium, which subsequently must continue to develop to accommodate the growing and maturing embryo and then fetus. This process is normally regulated by hormonal interactions between the fetal, endometrial and luteal tissue. It has been found that after IVF additional support for the endometrium with progesterone improves implantation and subsequent live birth rates in IVF cycle . Recent data has shown that additional supplementation with a single administration of a GnRH agonist around the time the time of embryo transfer may further enhance these rates .


Study summary:

see above


Criteria:

Inclusion Criteria: - women undergoing IVF/ICSI or frozen embryo transfers (FET) that less than 40 years old. Exclusion Criteria: - day 3 transfers


NCT ID:

NCT02357654


Primary Contact:

Principal Investigator
Peter G McGovern, MD
Rutgers-New Jersey Medical School

Peter G McGovern, MD
Phone: 201-288-6330
Email: mcgovepg@gmail.com


Backup Contact:

N/A


Location Contact:

Hasbrouck Heights, New Jersey 07604
United States



There is no listed contact information for this specific location.

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: June 25, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.